+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors Part A. International Review of Neurobiology Volume 171

  • Book

  • September 2023
  • Region: Global
  • Elsevier Science and Technology
  • ID: 5790058

Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors, Volume 171 in the International Review of Neurobiology series, highlights new advances in the field with this new volume presenting interesting chapters on Neurodegenerative diseases, Stress induced exacerbation of Alzheimer's disease brain pathology is thwarted by co-administration of nanowired cerebrolysin and amyloid beta peptide antibodies with serotonin 5-HT6 receptor antagonist SB-39988, Nanowired delivery of dl-3-n-butylphthalide with antibodies to alpha synuclein potentiated neuroprotection in Parkinson's disease with emotional stress, Efficacy of invasive and non-invasive methods for the treatment of Parkinson�s disease: nanodelivery and enriched environment, and much more.

Other sections cover Sleep deprivation induced exacerbation of Parkinson's disease pathophysiology is attenuated by co-administration of nanowired cerebrolysin and serotonin-3 receptor antagonist ondansetron, Co-administration of DL-3-n-butylphthalide and neprilysin is neuroprotective in Alzheimer disease associated with brain injury, Stress and brain diseases, Pathophysiology of sleep deprivation enhances amyloid beta peptide and p-tau in the CSF and brain, Neuroprotective effects of nanowired delivery of multimodal drug cerebrolysin and monoclonal 5-HT antibodies, Prior heat exposure exacerbates brain blast injury, Neuroprotection by nanodelivery of cerebrolysin with serotonin 6 receptor antagonist SB-399885, the Effects of curcumin nanodelivery on several brain pathologies, and more.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

Section I: Neurodegenerative diseases Stress induced exacerbation of Alzheimer's disease brain pathology is thwarted by co-administration of nanowired cerebrolysin and amyloid beta peptide antibodies with serotonin 5-HT6 receptor antagonist SB-399885 Nanowired delivery of dl-3-n-butylphthalide with antibodies to alpha synuclein potentiated neuroprotection in Parkinson's disease with emotional stress Nanowired delivery of antibodies to tau and neuronal nitric oxide synthase together with cerebrolysin attenuates following traumatic brain injury induced exacerbation of brain pathology in Parkinson's disease Section II: Stress and brain pathology Pathophysiology of sleep deprivation enhances amyloid beta peptide and p-tau in the CSF and brain. Neuroprotective effects of nanowired delivery of multimodal drug cerebrolysin and monoclonal 5-HT antibodies Effects of curcumin nanodelivery on several brain pathologies Section III: Neurorepair and Neurorestoration Advances in Neurorestoratology: Current status and further developments Positive and negative cell therapy in randomized control trials for central nervous system diseases Nose-to-brain delivery : new developments and strategies Section V: Clinical Neurology Innovative emergency strategies for patients with severe traumatic brain injury: an IoT-based resource integration Efficacy and safety of acupuncture in the treatment of Post-traumatic headache secondary to mild traumatic brain injury: a systematic evaluation and meta-analysis protocol of randomized controlled trials Influence of clinical pathway on the therapeutic effect of skull minimally invasive aspiration and drainage for hypertensive intracerebral hemorrhage.